Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vance G Fowler

Showing results (251-260 of 426) with videos related to

Pageof 43
Sort By:
The Journal of Infectious Diseases|August 4, 2007
Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infectionVance G Fowler, Charlotte L Nelson, Lauren M McIntyre, et al.
Infection Control and Hospital Epidemiology|March 11, 2005
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremiaShelby D Reed, Joëlle Y Friedman, John J Engemann, et al.
Plos One|November 26, 2015
Polymorphisms in Fibronectin Binding Proteins A and B among Staphylococcus aureus Bloodstream Isolates Are Not Associated with Arthroplasty InfectionEmily M Eichenberger, Joshua T Thaden, Batu Sharma-Kuinkel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2008
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI SummitMarin H Kollef, Lena M Napolitano, Joseph S Solomkin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2022
Black and White Patients With Staphylococcus aureus Bacteremia Have Similar Outcomes but Different Risk FactorsFelicia Ruffin, Michael Dagher, Lawrence P Park, et al.
Trials|April 1, 2016
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trialSteven Y C Tong, Jane Nelson, David L Paterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2026
The innate immune protein calprotectin ablates the bactericidal activity of β-lactam antibioticsAmanda Z Velez, Jana N Radin, Emily N Kennedy, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Relationship between Vancomycin MIC and Virulence Gene Expression in Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus Strains Isolated from Left-Sided EndocarditisJuan M Pericàs, Carlos Cervera, Cristina Garcia-de-la-Mària, et al.
ACS Infectious Diseases|June 12, 2025
An Engineered Prodrug Selectively Suppresses β-Lactam-Resistant Bacteria in a Mixed Microbial SettingAddison M Duda, Helena R Ma, César A Villalobos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2005
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteriaMartin E Stryjewski, William D O'Riordan, William K Lau, et al.
Pageof 43

Showing results (251-260 of 426) with videos related to

Sort By:
Pageof 43
The Journal of Infectious Diseases|August 4, 2007
Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infectionVance G Fowler, Charlotte L Nelson, Lauren M McIntyre, et al.
Infection Control and Hospital Epidemiology|March 11, 2005
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremiaShelby D Reed, Joëlle Y Friedman, John J Engemann, et al.
Plos One|November 26, 2015
Polymorphisms in Fibronectin Binding Proteins A and B among Staphylococcus aureus Bloodstream Isolates Are Not Associated with Arthroplasty InfectionEmily M Eichenberger, Joshua T Thaden, Batu Sharma-Kuinkel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2008
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI SummitMarin H Kollef, Lena M Napolitano, Joseph S Solomkin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2022
Black and White Patients With Staphylococcus aureus Bacteremia Have Similar Outcomes but Different Risk FactorsFelicia Ruffin, Michael Dagher, Lawrence P Park, et al.
Trials|April 1, 2016
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trialSteven Y C Tong, Jane Nelson, David L Paterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2026
The innate immune protein calprotectin ablates the bactericidal activity of β-lactam antibioticsAmanda Z Velez, Jana N Radin, Emily N Kennedy, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Relationship between Vancomycin MIC and Virulence Gene Expression in Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus Strains Isolated from Left-Sided EndocarditisJuan M Pericàs, Carlos Cervera, Cristina Garcia-de-la-Mària, et al.
ACS Infectious Diseases|June 12, 2025
An Engineered Prodrug Selectively Suppresses β-Lactam-Resistant Bacteria in a Mixed Microbial SettingAddison M Duda, Helena R Ma, César A Villalobos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2005
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteriaMartin E Stryjewski, William D O'Riordan, William K Lau, et al.
Pageof 43